‘A Lot of Fear’: Trump Admin Pressures Countries to Expel Cuban Doctors, Memo Reveals

19,000 Cuban healthcare professionals operate across 16 Western Hemisphere countries, per a Feb. 23 State Department memo directing efforts to persuade governments to expel Cuban doctors. The memo offers U.S. support (telemedicine, training, recruitment) as incentives; Honduras and Jamaica have recently ended partnerships amid U.S. pressure. U.S. officials argue the missions are a major revenue source for Havana and represent >20% of the medical workforce in some nations, creating near-term regional political and healthcare-delivery risk.

Analysis

This push to remove Cuban medical missions creates an immediate, quantifiable service gap in multiple small healthcare systems that cannot be backfilled by native capacity. In jurisdictions where Cuban doctors comprise >15-20% of the workforce, expect primary-care vacancy rates to spike by double digits within 0-6 months, producing urgent demand for telemedicine, contract staffing, and short-term migrant nurses.

Fiscal and political spillovers will show up as higher near-term healthcare budgets and wage inflation for nurses and primary-care providers; governments will either (a) raise spending/cut elsewhere, worsening fiscal deficits and sovereign spreads within 3-12 months, or (b) speed recruitment from global nursing exporters (Philippines/India), transmitting wage pressure into the global staffing market. This reallocation also raises migration risk and remittance flows, creating measurable revenue upside for payments processors and downside for small tourism-dependent economies facing reputational/political blowback.

Market winners are narrow and tactical: telemedicine platforms and specialist staffing firms that can credibly supply primary-care capacity at scale; losers are small Caribbean/Latin sovereigns and local-currency assets that will face tighter fiscal dynamics and FX depreciation. The policy campaign is not binary — a staggered, country-by-country unraveling over 3-18 months is the base case, with key catalysts being bilateral aid packages, IMF/World Bank interventions, and elections in affected jurisdictions.

Tail risks include social unrest or migration shocks (6-24 months) that could materially widen sovereign CDS and force emergency multilateral support; the primary reversal mechanism is rapid third-party substitution (India/China/NGOs) or a change in US administration posture, both of which could blunt the commercial opportunities outlined below.

Key Decisions for Investors

• Long TDOC (Teladoc) 3–9 months: buy 3–6 month ATM call options or a 5% sized long-equity position. Rationale: fastest credible substitute for in-person primary care; target 20–40% upside if multiple smaller Caribbean/Latin contracts announced. Risk: slow procurement/reimbursement adoption — set 20% stop-loss on equity or sell calls at 30% gain.
• Long AMN (AMN Healthcare) 3–12 months: initiate 4–6% portfolio exposure in equity or buy 9–12 month calls. Rationale: direct beneficiary from urgent nurse/physician staffing demand and short-term deployments. Risk/reward: pay 25–40% premium for time options; breakeven if only limited contract wins — trim to half position at +25%.
• Long WU (Western Union) 0–12 months: buy January 2027 LEAPS or add 3–6% tactical long. Rationale: migration/remittance upside as healthcare displacement and instability increases cash flow corridors; expected 10–30% upside in stressed scenarios. Downside: fintech substitution/regulatory squeeze — hedge with 25% position size and 10% stop-loss.
• Hedge/relative short: buy UUP (Dollar Index ETF) or long USD via FX forwards 0–6 months while shorting EM-latam exposure (small position in EEM) as a pair trade. Rationale: fiscal stress and tariff/policy friction should favor USD and depress small Caribbean/LatAm sovereign assets; target asymmetric 2:1 payoff. Risk: broad EM rally or rapid multilateral aid — cap notional exposure to 3–5% NAV.